Roman Health Pharmacy LLC
“you may select Roman Health Pharmacy LLC or one of our partner pharmacies (collectively, the 'Ro Pharmacy Network')”
GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Ro rates best on simply being available where you are.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Prices checked September 2026
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Yes. Ro is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Ro has no code to type in. The current offer: $39 for the first month, then $149/month (as low as $74/month with annual prepay); membership only, medication separate. It applies at checkout on its own. Coupon sites advertising a "Ro promo code" are not a source we can vouch for.
See how Ro compares on our rankings of the best weight-loss injection providers.
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something Ro has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
$149/month is exactly the median for brand-name orforglipron across the sellers we compare.
Dispenses orforglipron, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
A price is shown before the questionnaire starts.
It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Serves 50 of 50 states.
The price covers clinician visits, lab work and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
Taken from the terms Ro publishes. Terms change, so check the current policy before you subscribe.
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Prices re-verified
Additional membership fees apply
Check the price yourself before you pay
Every figure here was read off Ro's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Each partner below is a 503A or 503B pharmacy that Ro routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
“you may select Roman Health Pharmacy LLC or one of our partner pharmacies (collectively, the 'Ro Pharmacy Network')”
The standing price at Ro is $149/month.
For brand-name orforglipron, the median across the sellers we compare is $149/month, so Ro's $149 lands mid-market. Price is unlikely to be the deciding factor.
HealthRX dispenses semaglutide and tirzepatide from $133/month, which makes it the fair comparison to run before you commit here.
Ro prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed.
Ro tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and the pharmacy that fills its prescriptions. It also offers coaching as part of the plan. We found no FDA warning letters issued to Ro. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Ro lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Found is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Ro rates best on simply being available where you are.
Starting at $149 a month. Check today's price, then start the intake.
The sellers closest to Ro on medication and price.
The words sellers use, defined. Tap any term.
Cited across this Ro review: primary regulatory filings, and peer-reviewed studies.
Plans start at $149 a month. Whether you qualify is a clinician's decision, made after your intake.